A new device (transcutaneous stimulator) for leg strength and walking in children with spina bifida

You may qualify if

• Diagnosed myelomeningocele confirmed by a neurosurgeon or neurologist
• Some difficulty ambulating, but able to ambulate at least a short distance (10 meters) with devices and/or assistance.
• Between the ages of 4 and 17 years of age.
• Documented neurogenic bladder dysfunction
• On a stable bladder management regimen at least 4-6 weeks prior to the enrollment in the trial

You can't join if

• Severe behavioral or cognitive impairments that preclude participation in the study, in the opinion of the investigator.
• Has an active surgery planned for impairments from spina bifida (e.g. tethered cord syndrome surgery or orthopedic surgery) or has had surgery in the last 6 months.
• Is pregnant. Pregnancy will be assessed via verbal report.
• Open wounds at the thoracic or lumbar spine that precludes transcutaneous stimulation.
• Implanted or attached electronic device in any location of the body (e.g. pacemakers, baclofen pumps, or implanted insulin pumps)
• Symptomatic urinary tract infection, urinary tract infection for which they are currently receiving treatment, scheduled urological surgery, or inability to perform or receive catheterization.